We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTO
1626
DELISTED
Vista Outdoor Inc.
VSTO
$1.25M ﹤0.01%
26,289
+4,092
+18% +$198K
AWH
1627
DELISTED
Allied World Assurance Co Hld Lt
AWH
$1.25M ﹤0.01%
35,485
-610
-2% -$22K
GEO icon
1628
The GEO Group
GEO
$4B
$1.25M ﹤0.01%
54,674
+5,613
+11% +$124K
HTD
1629
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$904M
$1.25M ﹤0.01%
50,000
SLGN icon
1630
Silgan Holdings
SLGN
$4.46B
$1.25M ﹤0.01%
48,416
+6,800
+16% +$175K
OLN icon
1631
Olin
OLN
$2.17B
$1.24M ﹤0.01%
49,807
+84
+0.2% +$1.81K
CY
1632
DELISTED
Cypress Semiconductor
CY
$1.23M ﹤0.01%
116,895
+4,300
+4% +$41K
BXMT icon
1633
Blackstone Mortgage Trust
BXMT
$2.44B
$1.23M ﹤0.01%
44,300
+10,200
+30% +$281K
MORN icon
1634
Morningstar
MORN
$7.76B
$1.22M ﹤0.01%
14,941
+1,592
+12% +$133K
ALE
1635
DELISTED
Allete
ALE
$1.22M ﹤0.01%
18,870
+4,425
+31% +$255K
SKT icon
1636
Tanger
SKT
$4.42B
$1.21M ﹤0.01%
29,985
-95,000
-76% -$3.46M
IBKC
1637
DELISTED
IBERIABANK Corp
IBKC
$1.2M ﹤0.01%
20,133
+2,028
+11% +$118K
AMD icon
1638
Advanced Micro Devices
AMD
$789B
$1.2M ﹤0.01%
233,905
-113,955
-33% -$443K
ALR
1639
DELISTED
Alere Inc
ALR
$1.2M ﹤0.01%
28,836
-580
-2% -$25.2K
BRX icon
1640
Brixmor Property Group
BRX
$9.21B
$1.2M ﹤0.01%
45,195
+25
+0.1% +$641
VMW
1641
DELISTED
VMware, Inc
VMW
$1.2M ﹤0.01%
20,880
+1,710
+9% +$98.6K
BV
1642
DELISTED
Bazaarvoice, Inc.
BV
$1.19M ﹤0.01%
297,022
BYD icon
1643
Boyd Gaming
BYD
$6.05B
$1.19M ﹤0.01%
64,600
LDOS icon
1644
Leidos
LDOS
$17.9B
$1.18M ﹤0.01%
24,650
+473
+2% +$23.4K
THG icon
1645
Hanover Insurance
THG
$7.77B
$1.18M ﹤0.01%
13,947
+62
+0.4% +$5.33K
LXK
1646
DELISTED
Lexmark Intl Inc
LXK
$1.18M ﹤0.01%
31,127
HUN icon
1647
Huntsman Corp
HUN
$1.81B
$1.17M ﹤0.01%
87,154
+28,333
+48% +$416K
SEDG icon
1648
SolarEdge
SEDG
$1.98B
$1.17M ﹤0.01%
59,736
USG
1649
DELISTED
Usg
USG
$1.17M ﹤0.01%
43,445
-9,900
-19% -$270K
SANM icon
1650
Sanmina
SANM
$11.1B
$1.17M ﹤0.01%
43,452
+4,200
+11% +$105K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.